Panagora Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-42,001
| Closed | -$2.86M | – | 1548 |
|
|
2022
Q3 | $2.86M | Sell |
42,001
-61,563
| -59% | -$4.19M | 0.02% | 508 |
|
|
2022
Q2 | $3.31M | Buy |
103,564
+8,190
| +9% | +$262K | 0.02% | 489 |
|
|
2022
Q1 | $3.3M | Buy |
95,374
+5,086
| +6% | +$176K | 0.02% | 525 |
|
|
2021
Q4 | $2.64M | Buy |
+90,288
| New | +$2.64M | 0.01% | 560 |
|
|
2021
Q3 | – | Sell |
-2,790
| Closed | -$98K | – | 2708 |
|
|
2021
Q2 | $98K | Sell |
2,790
-201
| -7% | -$7.06K | ﹤0.01% | 1908 |
|
|
2021
Q1 | $122K | Buy |
2,991
+2,628
| +724% | +$107K | ﹤0.01% | 1892 |
|
|
2020
Q4 | $16K | Sell |
363
-24
| -6% | -$1.06K | ﹤0.01% | 2232 |
|
|
2020
Q3 | $21K | Buy |
387
+50
| +15% | +$2.71K | ﹤0.01% | 2200 |
|
|
2020
Q2 | $21K | Buy |
+337
| New | +$21K | ﹤0.01% | 2136 |
|
|
2017
Q3 | – | Sell |
-714
| Closed | -$20K | – | 2556 |
|
|
2017
Q2 | $20K | Buy |
+714
| New | +$20K | ﹤0.01% | 2276 |
|
|
2016
Q1 | – | Sell |
-5,908
| Closed | -$191K | – | 2359 |
|
|
2015
Q4 | $191K | Buy |
+5,908
| New | +$191K | ﹤0.01% | 1604 |
|